Full-Time
Posted on 7/22/2025
Rapid physician consultations using real-world data
$165k - $185k/yr
No H1B Sponsorship
Remote in USA
Remote
Candidates must be currently authorized to work in the United States on a full-time basis. No visa sponsorship is available.
| , , , |
Atropos Health delivers physician-focused real-world evidence through a digital consultation service that helps clinicians answer complex questions by querying patient data. Clinicians submit a clinical question and, within 24 hours, receive insights derived from observational research and real-world data developed over five years at Stanford. The service is offered on a subscription basis to healthcare providers, hospitals, and research institutions, with potential partnerships with pharmaceutical companies. Its goal is to close the evidence gap in medical decision-making by making real-world data actionable for physicians, researchers, and healthcare organizations.
Company Size
51-200
Company Stage
Series B
Total Funding
$47M
Headquarters
Palo Alto, California
Founded
2019
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
401(k) Retirement Plan
Parental Leave
Flexible Work Hours
Remote Work Options
Home Office Stipend
Atropos Health has announced a collaboration with Microsoft Dragon Copilot at Stanford Medicine, integrating its Evidence Agent into the electronic health record system. The AI-powered tool provides physicians with personalised real-world evidence at the point of care, drawing from Stanford's clinical data including information generated by Dragon Copilot. The Atropos Evidence Agent is now available in the Microsoft Teams Store, allowing clinicians to download it for care team collaboration. The technology generates evidence-based summaries relevant to individual patients without disrupting clinical workflow. Atropos Health, which operates GENEVA OS for rapid healthcare evidence generation, is part of Microsoft's invite-only Pegasus Program for startups. The company is demonstrating the capability at the 2026 HIMSS conference in Las Vegas.
Atropos Health announces key new hires to scale high quality evidence utilization in the healthcare ecosystem. Atropos Health announces the addition of two new hires to the leadership team, including the company's first Chief Technology Officer and Chief Financial Officer. Sylvia Isler joins as Chief Technology Officer and Drew Turitz as Chief Financial Officer. The addition of these two team members expands the companies' domain knowledge across the healthcare ecosystem including telehealth, payers and big tech.
Atropos Health, a company translating real-world clinical data into personalised evidence, has appointed Sylvia Isler as Chief Technology Officer and Drew Turitz as Chief Financial Officer. The hires expand the company's expertise across telehealth, payers and big tech. Isler brings over 20 years of experience leading engineering and IT organisations at Google, Better Life Partners and Cityblock Health. She holds a PhD in Computer Science from the University of Massachusetts Lowell. Turitz has more than 20 years in healthcare finance, previously serving as CFO of Fuze Health and spending a decade at Teladoc leading corporate development. He earned an MBA from Northwestern University's Kellogg School of Management. The appointments follow Atropos Health's recent hire of Kevin Smith as Chief Growth Officer.
Atropos Health named to the 2026 New York Digital Health 100. Atropos Health has been named to the 2026 New York Digital Health 100 (DH100), an annual recognition honoring the most innovative and high-impact digital health startups in the New York region. Published by Digital Health New York (DHNY), the DH100 is released in conjunction with the 2026 New York Healthcare Innovation Report, which analyzes key investment trends, market dynamics, and opportunities shaping the digital health ecosystem.
Atropos Health announces ai-driven Commercial Analytics solution for life science companies. Atropos Health today announced the availability of Commercial Analytics solutions for life science leaders. This is an extension to the already growing number of solutions available to life science companies to accelerate decision making across the Real World Data(RWD), Research & Development (R&D), Health Economics and Outcomes Research (HEOR)/Medical, and Brand use cases. The solution leverages the speed and accuracy of ChatRWD(R) to generate rapid answers while transparently displaying actionable insights. Commercial and brand leaders generate high-quality, brand-specific insights delivered in seconds with not only the visuals they need - but also the data behind the dashboards.